Neena S Abraham
Biographic Data
| ID | 202357 |
|---|---|
| NAME | Neena S Abraham |
| GIVEN NAMES | Neena S |
| FAMILY NAME | Abraham |
| SIGNATURE | ABRAHAM N S |
| AFFILIATIONS | Houston Center of Quality of Care and Utilization Studies at Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA |
| ORCID | 0000-0002-8532-6354 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2010 |
| H-INDEX | 0 |
Understanding Risk Communication Through Patient Narratives About Complex Antithrombotic Therapies
The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts…
Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations
OBJECTIVES: We sought to operationalize, test, and validate an outpatient pharmacy-based case-mix adjuster. METHODS: Outpatients from the Department of Veterans Affairs (VA) prescribed a nonsteroidal anti-inflammatory drug (NSAID) or cyclooxygenase-2 selective drug during 2002 were identified. We updated and extended the Rx-Risk-V by adding 26 additional disease categories and mapping them to VA drug-class codes; derived empirical weights for eac…
No prominent works on this page.
Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations
OBJECTIVES: We sought to operationalize, test, and validate an outpatient pharmacy-based case-mix adjuster. METHODS: Outpatients from the Department of Veterans Affairs (VA) prescribed a nonsteroidal anti-inflammatory drug (NSAID) or cyclooxygenase-2 selective drug during 2002 were identified. We updated and extended the Rx-Risk-V by adding 26 additional disease categories and mapping them to VA drug-class codes; derived empirical weights for eac…
Understanding Risk Communication Through Patient Narratives About Complex Antithrombotic Therapies
The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts…
Family medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Adverse effect (1 works) · Ambiguity (1 works) · Antithrombotic (1 works) · Aspirin (1 works) · Chronic Disease Management Strategies (1 works) · Cohort (1 works) · Cohort study (1 works)